Related Experiment Videos
[Apolipoprotein AI levels in cord blood]
S Kobayashi1, M Tanaka, K Masaki
1First Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo.
Nihon Sanka Fujinka Gakkai Zasshi
|January 1, 1992
Summary
Apolipoprotein AI levels in umbilical cord blood may help evaluate preeclamptic pregnancies. This biomarker shows potential for assessing pregnancy complications, offering insights into maternal and infant health during gestation.
Area of Science:
- Biochemistry
- Obstetrics
- Neonatal Medicine
Context:
- Lipid metabolism significantly alters during pregnancy.
- Preeclamptic pregnancies exhibit elevated lipid concentrations compared to normal pregnancies.
- Apolipoproteins are crucial determinants of lipoprotein metabolism and structure.
Purpose:
- To investigate the role of apolipoprotein AI in pregnancy, particularly in relation to preeclampsia.
- To determine cord apolipoprotein AI levels and their correlation with various maternal and infant factors.
Summary:
- This study measured cord apolipoprotein AI levels in 26 healthy pregnant women using TIA methods, finding mean levels of 76.12 +/- 20.04 mg/dl.
- Cord apolipoprotein AI levels showed correlations with maternal age, maternal weight, gestational week, infant weight, placental weight, and diastolic blood pressure.
- These findings suggest that cord apolipoprotein AI measurement could be a valuable tool for evaluating preeclamptic pregnancies.
Impact:
- Provides a potential biomarker for assessing preeclampsia risk and severity.
- Enhances understanding of lipid metabolism alterations during pregnancy and their implications.
- Offers a novel approach for monitoring maternal-fetal health outcomes in high-risk pregnancies.